...
首页> 外文期刊>Journal of Infectious Diseases >A New Recombinant Bacille Calmette-Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers
【24h】

A New Recombinant Bacille Calmette-Guérin Vaccine Safely Induces Significantly Enhanced Tuberculosis-Specific Immunity in Human Volunteers

机译:一种新的重组BacilleCalmette-Guérin重组疫苗可安全地诱导人类志愿者显着增强的结核病特异性免疫力

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background. One strategy for improving anti-tuberculosis (TB) vaccination involves the use of recombinant bacille Calmette-Guérin (rBCG) overexpressing protective TB antigens. rBCG30, which overexpresses the Mycobacterium tuberculosis secreted antigen Ag85b, was the first rBCG shown to induce significantly greater protection against TB in animals than parental BCG.
机译:背景。改善抗结核(TB)疫苗接种的一种策略涉及使用过度表达保护性TB抗原的重组杆菌Calmette-Guérin(rBCG)。过度表达结核分枝杆菌分泌的抗原Ag85b的rBCG30是第一个显示出比亲本BCG诱导明显增强的动物抗结核保护作用的rBCG。

著录项

  • 来源
    《Journal of Infectious Diseases》 |2008年第10期|p.1491-1501|共11页
  • 作者单位

    1Division of Immunobiology Departments of Internal Medicine and Molecular Biology, Saint Louis University Medical Center, and Center for Vaccine Development, Saint Louis, Missouri 2Laboratory of Mycobacterial Immunity and Pathogenesis, Public Health Research Institute, University of Medicine and Dentistry of New Jersey 3Aeras Global TB Vaccine Foundation, Rockville Pike, Maryland 4Departments of Internal Medicine and of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles 5South African Tuberculosis Vaccine Initiative, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号